Continuous neuromuscular blockade for severe ARDS became common practice after the ACURASYS trial (2010) showed it reduced mortality by an absolute 9%.
Neuromuscular blockade for ARDS was no help, in supine patients
Neuromuscular blockade for ARDS was no help…
Neuromuscular blockade for ARDS was no help, in supine patients
Continuous neuromuscular blockade for severe ARDS became common practice after the ACURASYS trial (2010) showed it reduced mortality by an absolute 9%.